MADRID (Reuters) - Spain's medicines agency authorised the launch of late-stage trials of Johnson & Johnson's COVID-19 vaccine on Wednesday as the race to develop successful vaccines intensifies.
The Phase III trial of the two-dose vaccination will be carried out in nine hospitals throughout Spain on volunteers both with and without previous health conditions, the AEMPS agency said in a statement.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!